Literature DB >> 26240050

Is Intake of Flavonoid-Based Food Supplements During Pregnancy Safe for the Developing Child? A Literature Review.

Marta Barenys, Stefan Masjosthusmann, Ellen Fritsche1.   

Abstract

Due to potential health benefits and the general assumption that natural products are safe, there is an increasing trend in the general population - including pregnant women - to supplement their diet with flavonoid-based food supplements. In addition, preclinical studies aim to prevent developmental adverse effects induced by toxic substances, infections, maternal or genetic diseases of the unborn child by administration of flavonoids at doses far above those reached by normal diets. Because these substances do not undergo classical risk assessment processes, our aim was to review the available literature on the potential adverse effects of maternal diet supplementation with flavonoid-based products for the developing child. A systematic literature search was performed in three databases and screened following four exclusion criteria. Selected studies were classified into two groups: 1. Studies on the developmental toxicity of single flavonoids in vitro or in animals in vivo, and 2. Studies on the developmental toxicity of single flavonoids or on flavonoid-mixtures in humans. The data collected indicate that there is a concern for the safety of some flavonoids within realistic human exposure scenarios. This concern is accompanied by a tremendous lack of studies on safety of these compounds during development making definite safety decisions impossible. Besides studies of survival, especially the more specific developmental processes like nervous system development need to be addressed experimentally. Before new high-dose, flavonoid-based therapeutic strategies are developed for pregnant women further research on the safety of these compounds is clearly needed. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Adverse effects; development; flavonoids; food supplements; herbal-based products; pregnancy; toxicity.

Mesh:

Substances:

Year:  2017        PMID: 26240050     DOI: 10.2174/1389450116666150804110049

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  4 in total

1.  Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro.

Authors:  Jördis Klose; Lu Li; Xiaohui Fan; Ellen Fritsche; Melanie Pahl; Farina Bendt; Ulrike Hübenthal; Christian Jüngst; Patrick Petzsch; Astrid Schauss; Karl Köhrer; Ping Chung Leung; Chi Chiu Wang; Katharina Koch; Julia Tigges
Journal:  Cell Biol Toxicol       Date:  2022-06-15       Impact factor: 6.691

2.  The genotoxicity potential of luteolin is enhanced by CYP1A1 and CYP1A2 in human lymphoblastoid TK6 cells.

Authors:  Xilin Li; Xiaobo He; Si Chen; Yuan Le; Matthew S Bryant; Lei Guo; Kristine L Witt; Nan Mei
Journal:  Toxicol Lett       Date:  2021-03-13       Impact factor: 4.271

3.  Supplementation with Achyrocline satureioides Inflorescence Extracts to Pregnant and Breastfeeding Rats Induces Tissue-Specific Changes in Enzymatic Activity and Lower Neonatal Survival.

Authors:  Karla Suzana Moresco; Alexandre Kleber Silveira; Carlos Eduardo Schnorr; Fares Zeidán-Chuliá; Rafael Calixto Bortolin; Leonardo da Silva Bittencourt; Moara Mingori; Luana Heimfarth; Thallita Kelly Rabelo; Maurilio da Silva Morrone; Juliana Poglia Carini; Daniel Pens Gelain; Valquiria Linck Bassani; José Cláudio Fonseca Moreira
Journal:  Biomedicines       Date:  2017-08-29

4.  Scientific Validation of Human Neurosphere Assays for Developmental Neurotoxicity Evaluation.

Authors:  Katharina Koch; Kristina Bartmann; Julia Hartmann; Julia Kapr; Jördis Klose; Eliška Kuchovská; Melanie Pahl; Kevin Schlüppmann; Etta Zühr; Ellen Fritsche
Journal:  Front Toxicol       Date:  2022-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.